Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Mar;63(3):348–350. doi: 10.1038/bjc.1991.83

New bone formation and cancer implants; relationship to tumour proliferative activity.

R Nemoto 1
PMCID: PMC1971865  PMID: 2003975

Abstract

The interaction between tumour and bone with respect to the proliferative activity of transplanted tumour cells was studied using five transplantable human urogenital tumours in nude mice. Cells from those tumours were injected subcutaneously over the calvaria of nude mice following disruption of the periosteum. The extent of tumour-bone interaction varied with the type of implanted tumour as shown on X-ray and by histologic examinations of the calvaria. The classic histologic pattern of bone remodelling including the destruction of bone with proliferation of osteoclasts and reactive new bone formation was seen with all five tumours. Tumour proliferative activity determined from the tumour doubling time and the S-phase fraction using bromodeoxyuridine labelling showed that the rate of reactive bone formation appeared to be inversely proportional to the rate of tumour cell proliferation.

Full text

PDF
348

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fornasier V. L., Horne J. G. Metastases to the vertebral column. Cancer. 1975 Aug;36(2):590–594. doi: 10.1002/1097-0142(197508)36:2<590::aid-cncr2820360240>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  2. Galasko C. S. The pathological basis for skeletal scintigraphy. J Bone Joint Surg Br. 1975 Aug;57(3):353–359. [PubMed] [Google Scholar]
  3. Gratzner H. G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982 Oct 29;218(4571):474–475. doi: 10.1126/science.7123245. [DOI] [PubMed] [Google Scholar]
  4. Nemoto R., Hattori K., Uchida K., Shimazui T., Nishijima Y., Koiso K., Harada M. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling. Cancer. 1990 Aug 1;66(3):509–514. doi: 10.1002/1097-0142(19900801)66:3<509::aid-cncr2820660318>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Nemoto R., Kanoh S., Koiso K., Harada M. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice. J Urol. 1988 Oct;140(4):875–879. doi: 10.1016/s0022-5347(17)41848-9. [DOI] [PubMed] [Google Scholar]
  6. Nemoto R., Sato S., Nishijima Y., Miyakawa I., Koiso K., Harada M. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice. J Urol. 1990 Sep;144(3):770–774. doi: 10.1016/s0022-5347(17)39589-7. [DOI] [PubMed] [Google Scholar]
  7. Nemoto R., Uchida K., Tsutsumi M., Koiso K., Satou S., Satou T. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium. J Cancer Res Clin Oncol. 1987;113(6):539–543. doi: 10.1007/BF00390862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Parfitt A. M. Bone histomorphometry: proposed system for standardization of nomenclature, symbols, and units. Calcif Tissue Int. 1988 May;42(5):284–286. doi: 10.1007/BF02556360. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES